BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
352.96
-16.04 (-4.35%)
Feb 25, 2026, 12:15 PM EST - Market open

BeOne Medicines AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
39,05819,66718,86222,84327,84323,494
Market Cap Growth
63.96%4.27%-17.43%-17.96%18.51%131.83%
Enterprise Value
35,83118,00516,44119,59724,62619,028
Last Close Price
369.00184.71180.36219.94270.93258.39
PS Ratio
7.815.167.6716.1323.6776.06
PB Ratio
9.895.905.335.214.546.07
P/TBV Ratio
9.555.995.425.264.586.08
P/OCF Ratio
49.46-----
EV/Sales Ratio
7.214.726.6913.8420.9461.60
Debt / Equity Ratio
0.250.320.260.140.110.14
Net Debt / Equity Ratio
-0.73-0.46-0.63-0.90-0.97-1.06
Net Debt / EBITDA Ratio
-9.193.851.992.284.252.52
Net Debt / FCF Ratio
-5.542.441.302.163.802.92
Asset Turnover
0.740.650.400.190.170.09
Inventory Turnover
1.431.301.091.090.9923.18
Quick Ratio
2.091.511.973.224.454.40
Current Ratio
2.391.802.323.554.764.61
Return on Equity (ROE)
1.81%-18.77%-22.26%-38.11%-29.15%-67.19%
Return on Assets (ROA)
1.69%-6.07%-12.40%-15.00%-12.72%-28.73%
Return on Capital Employed (ROCE)
3.50%-15.40%-30.30%-36.40%-20.70%-36.60%
Earnings Yield
0.18%-3.28%-4.67%-8.77%-5.24%-6.92%
FCF Yield
1.40%-3.22%-9.12%-7.98%-5.61%-5.96%
Buyback Yield / Dilution
-6.60%-0.86%-1.22%-11.15%-11.16%-38.99%
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q